CervoMed Inc. Stock Issued During Period, Value, Conversion of Convertible Securities
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- CervoMed Inc. stock issued during period, value, conversion of convertible securities for the quarter ending 2023-12-31 was $0.00.
- CervoMed Inc. stock issued during period, value, conversion of convertible securities for the quarter ending 2023-09-30 was $6.99M.
- CervoMed Inc. stock issued during period, value, conversion of convertible securities for the quarter ending 2021-12-31 was $0.00.
- CervoMed Inc. stock issued during period, value, conversion of convertible securities for the quarter ending 2021-09-30 was $0.00, a 100.00% decline year-over-year.
- CervoMed Inc. stock issued during period, value, conversion of convertible securities for fiscal 2023 was $6.99M.
- CervoMed Inc. stock issued during period, value, conversion of convertible securities for fiscal 2021 was $2.20M, a 71.73% decline from fiscal 2020.
- CervoMed Inc. stock issued during period, value, conversion of convertible securities for fiscal 2020 was $7.79M, a 100.27% increase from fiscal 2019.
- CervoMed Inc. stock issued during period, value, conversion of convertible securities for fiscal 2019 was $3.89M.
| Period end | Stock Issued During Period, Value, Conversion of Convertible Securities 3 month | Stock Issued During Period, Value, Conversion of Convertible Securities 12 month |
|---|---|---|
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-17 | $6.99M 10-K · filed 2025-03-17 |
| 2023-09-30 | $6.99M 10-Q · filed 2024-11-12 | |
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-24 | $2.20M 10-K · filed 2023-03-24 |
| 2021-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | $2.20M derived: sum of 4 quarters · filed 2022-11-14 |
| 2021-06-30 | $0.00 10-Q · filed 2022-08-12 | $2.21M derived: sum of 4 quarters · filed 2022-08-12 |
| 2021-03-31 | $2.20M 10-Q · filed 2022-05-12 | $9.85M derived: sum of 4 quarters · filed 2022-05-12 |
| 2020-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-18 | $7.79M 10-K · filed 2022-03-18 |
| 2020-09-30 | $7.50K 10-Q · filed 2021-11-10 | |
| 2020-06-30 | $7.65M 10-Q · filed 2021-08-11 | |
| 2019-12-31 | $3.89M 10-K · filed 2021-03-17 | |
| 2016-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2018-04-02 | $711.50K 10-K · filed 2018-04-02 |
| 2016-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-14 | |
| 2016-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-15 | |
| 2016-03-31 | $711.50K 10-Q · filed 2016-05-16 | |
| 2015-12-31 | $19.70M 10-K · filed 2017-03-31 | |
| 2011-12-31 | -$51.00 10-K/A · filed 2013-04-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 | |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |